- Home
- KTTA vs CMND Comparison
KTTA vs CMND Comparison
Compare KTTA & CMND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KTTA
- CMND
- Stock Information
- Founded
- KTTA 2020
- CMND 2017
- Country
- KTTA United States
- CMND Canada
- Employees
- KTTA N/A
- CMND N/A
- Industry
- KTTA Biotechnology: Pharmaceutical Preparations
- CMND Biotechnology: Pharmaceutical Preparations
- Sector
- KTTA Health Care
- CMND Health Care
- Exchange
- KTTA Nasdaq
- CMND Nasdaq
- Market Cap
- KTTA 5.5M
- CMND 5.3M
- IPO Year
- KTTA 2021
- CMND N/A
- Fundamental
- Price
- KTTA $0.81
- CMND $0.97
- Analyst Decision
- KTTA
- CMND
- Analyst Count
- KTTA 0
- CMND 0
- Target Price
- KTTA N/A
- CMND N/A
- AVG Volume (30 Days)
- KTTA 93.8K
- CMND 2.0M
- Earning Date
- KTTA 11-12-2025
- CMND 09-11-2025
- Dividend Yield
- KTTA N/A
- CMND N/A
- EPS Growth
- KTTA N/A
- CMND N/A
- EPS
- KTTA N/A
- CMND N/A
- Revenue
- KTTA N/A
- CMND N/A
- Revenue This Year
- KTTA N/A
- CMND N/A
- Revenue Next Year
- KTTA N/A
- CMND N/A
- P/E Ratio
- KTTA N/A
- CMND N/A
- Revenue Growth
- KTTA N/A
- CMND N/A
- 52 Week Low
- KTTA $0.65
- CMND $0.80
- 52 Week High
- KTTA $5.45
- CMND $2.18
- Technical
- Relative Strength Index (RSI)
- KTTA 61.44
- CMND 41.98
- Support Level
- KTTA $0.70
- CMND $0.98
- Resistance Level
- KTTA $0.84
- CMND $1.05
- Average True Range (ATR)
- KTTA 0.03
- CMND 0.07
- MACD
- KTTA 0.01
- CMND -0.01
- Stochastic Oscillator
- KTTA 81.57
- CMND 12.72
About KTTA Pasithea Therapeutics Corp.
Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers. It leveraging in the fields of neuroscience, translational medicine, and drug development. Its pipeline includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia. Companies pipelines includes PAS-004 (Macrocyclic Small Module[MEK1/2]), PAS-003 (Monoclonal antibody),PAS-001 (Small Module).
About CMND Clearmind Medicine Inc.
Clearmind Medicine Inc is a psychedelic pharmaceutical biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorder. Its primary objective is to research and develop psychedelic-based compounds and attempt to commercialize them as regulated medicines, foods, or supplements. The company's intellectual portfolio currently consists of four patent families. The company intends to seek additional patents for its compounds whenever warranted and will remain opportunistic regarding the acquisition of additional intellectual property to build its portfolio.